Results 211 to 220 of about 425,993 (391)

An HCV Vaccine on the Fly [PDF]

open access: yesThe Journal of Infectious Diseases, 2019
Laidlaw, S, Dustin, L
openaire   +3 more sources

Tacrolimus‐Related Hepatic Sinusoidal Obstruction Syndrome in a Case Receiving Deceased Liver Donor Liver Transplantation

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yu‐Tsun Hsieh   +2 more
wiley   +1 more source

Very Early Recurrence Following Liver Resection for Intrahepatic Cholangiocarcinoma: Is It Predictable by Clinical Preoperative Factors?

open access: yesANZ Journal of Surgery, EarlyView.
ABSTRACT Background Approximately one‐quarter of patients undergoing resection for intrahepatic cholangiocarcinoma (ICC) experience very early recurrence (within 6 months after liver resection), which is associated with a poor prognosis. Identifying factors associated with very early recurrence may help optimize patient selection for surgery and avoid ...
Francesco Ardito   +7 more
wiley   +1 more source

HCV Antibody Positive Rate Observed in Periodic Checkup in Kitakyushu.

open access: bronze, 1994
Ryuzo Ueda   +3 more
openalex   +2 more sources

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy

open access: yesClinical Infectious Diseases, 2018
A. Boerekamps   +22 more
semanticscholar   +1 more source

Machine Learning‐Based Prediction of Life‐Threatening Complications During Hemodialysis in Hospitalized Patients With Poor General Conditions

open access: yesArtificial Organs, EarlyView.
A machine learning model using predialysis data predicted sudden events during or after hemodialysis with high accuracy (auROC: 0.889). The key predictors included emergency hospitalization, recent surgery, high heart rate, low albumin levels, and high CRP.
Naotaka Kato   +11 more
wiley   +1 more source

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.

open access: yesNew England Journal of Medicine, 2015
Michael P. Curry   +21 more
semanticscholar   +1 more source

Clinical and Genetic Associations in Cephalosporin‐Induced Liver Injury: Insights From the Drug‐Induced Liver Injury Network

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
Cephalosporin‐induced liver injury usually presents as a self‐limited, mixed, or cholestatic hepatitis without hypersensitivity features, typically developing 1 to 4 weeks after treatment. With cefazolin, it often occurs after a single parenteral dose. A strong genetic association has been found with HLA‐A*02:01, with more severe liver injury at onset.
Raj Vuppalanchi   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy